IL6 and myocardial infarction: Our results revealed that AROC significantly decreased the levels of pro‐inflammatory cytokines, including tumor necrosis factor‐alpha, interleukin (IL)‐1β, and IL‐6, in both myocardial and plasma samples from MI/R model mice (Figure 7H and Figure S11D, p values < 0.05).